Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin
Completed · Phase 3 · Has a placebo group
Conditions studied: Lung Cancer - Non Small Cell Squamous
In brief
The purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the lives of patients with squamous only non small cell lung cancer more than placebo plus Paclitaxel and Carboplatin.
Key facts
- Study ID
- NCT01285609
- Run by
- Bristol-Myers Squibb
- People needed
- 1289
- Starts
- 2011-01-16
- Expected to finish
- 2017-08-22
- Last updated by the study team
- 2020-06-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Non small cell lung cancer (NSCLC) - squamous cell
- Stage IV or recurrent NSCLC
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
You may not qualify if…
- Brain Metastases
- Autoimmune diseases
Where it is running
- Va Connecticut Healthcare System — West Haven, Connecticut, United States
- Lynn Cancer Institute Center For Hematology-Oncology — Boca Raton, Florida, United States
- Integrated Community Oncology Network — Jacksonville, Florida, United States
- University Of Illinois At Chicago Medical Center — Chicago, Illinois, United States
- Quincy Medical Group — Quincy, Illinois, United States
- Presence Medical Group Hematology Oncology — Skokie, Illinois, United States
- Southern Illinois University School Of Medicine — Springfield, Illinois, United States
- St. Francis Hospital & Health Centers — Indianapolis, Indiana, United States
- Floyd Memorial Cancer Center Of Indiana — New Albany, Indiana, United States
- Kentucky Cancer Clinic — Hazard, Kentucky, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Montgomery Cancer Center — Mount Sterling, Kentucky, United States
- St Joseph Mercy Hospital — Ypsilanti, Michigan, United States
- University Of Kansas Cancer Center — Kansas City, Missouri, United States
- Washington University School Of Medicine — St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Clinical Research Alliance, Inc. — Lake Success, New York, United States
- Durham Va Medical Center (111g) — Durham, North Carolina, United States
- Carolina Biooncology Institute — Huntersville, North Carolina, United States
- Novant Health Oncology Specialists — Lexington, North Carolina, United States
- Gabrail Cancer Center Research — Canton, Ohio, United States
- Oklahoma Oncology And Hematology, Pc Dba — Tulsa, Oklahoma, United States
- Kaiser Permanente Northwest Region — Portland, Oregon, United States
- Guthrie Medical Group, P.C. — Sayre, Pennsylvania, United States
- Sharp Memorial Hospital — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.